INKON Life Technology Co., Ltd.

Equities

300143

CNE100000XF6

Healthcare Facilities & Services

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 07/06/2024 am IST			5-day change	1st Jan Change
7.33 ^CNY	+2.09%		-6.27%	-31.04%

25/04	INKON Life Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
21/04	INKON Life Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Starmap Medicine and Technology Co., Ltd. Announces Appointments of Executives

August 17, 2017 at 09:01 pm IST

Starmap Medicine and Technology Co., Ltd. approved Huo Changying as non-independent director, Zhang Longping, Yang Depo and Hu Hailing appointed as independent director in EGM held on August 16, 2017.

Latest news about INKON Life Technology Co., Ltd.

INKON Life Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04	CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	21/04	CI
Tranche Update on INKON Life Technology Co., Ltd.'s Equity Buyback Plan announced on February 6, 2024.	01/04	CI
INKON Life Technology Co., Ltd. announces an Equity Buyback for CNY 80 million worth of its shares.	05/02	CI
INKON Life Technology Co., Ltd. authorizes a Buyback Plan.	05/02	CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/23/26	CI
Inkon Life Technology Co., Ltd. Announces Directorate Appointments	10/23/10	CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29/23/29	CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/23/27	CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	24/23/24	CI
INKON Life Technology to Set Up Medical Ecological Park for 566 Million Yuan	18/23/18	MT
Qingdao Haiyingkang Investment Co., Ltd. and INKON Life Technology Co., Ltd. completed the acquisition of Shenzhen Shengzhong Investment Enterprise (Limited Partnership) from a group of shareholders.	14/22/14	CI
Qingdao Haiyingkang Investment Co., Ltd. and INKON Life Technology Co., Ltd. agreed to acquire Shenzhen Shengzhong Investment Enterprise (Limited Partnership) from a group of shareholders for CNY 87.7 million.	27/22/27	CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	25/22/25	CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	23/22/23	CI
INKON Life Technology Co., Ltd. announced that it expects to receive CNY 999.999998 million in funding from Qingdao Yingkang Medical Investment Co., Ltd.	12/22/12	CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	28/22/28	CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22/22/22	CI
Tranche Update on INKON Life Technology Co., Ltd.'s Equity Buyback Plan announced on February 5, 2021.	11/22/11	CI
INKON Life Technology Co., Ltd.'s Equity Buyback announced on February 5, 2021, has expired with 2,509,317 shares, representing 0.39% for CNY 50 million.	11/22/11	CI
Tranche Update on INKON Life Technology Co., Ltd.'s Equity Buyback Plan announced on February 5, 2021.	04/22/04	CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	28/21/28	CI
Tranche Update on INKON Life Technology Co., Ltd.'s Equity Buyback Plan announced on February 5, 2021.	12/21/12	CI
INKON Life Technology Co., Ltd.(XSEC:300143) added to S&P Global BMI Index	20/21/20	CI
Qingdao Yingkang Medical Investment Co., Ltd. acquired Hangzhou Yikang Traditional Chinese Medicine Tumor Hospital Co., Ltd. from INKON Life Technology Co., Ltd. for CNY 1.3 million.	13/21/13	CI

Chart INKON Life Technology Co., Ltd.

Duration

Period

More charts

Company Profile

INKON Life Technology Co., Ltd., formerly Starmap medicine & technology Co., Ltd., is a China-based company principally engaged in providing medical services. Its medical services focus on cancer prevention, diagnosis, treatment and rehabilitation. The Company is also engaged in the research and development, manufacture and sales of medical equipment, as well as medical software development. Its medical equipment mainly include MASEP digital radiotherapy equipment, MASEP Gamma Knife and other large medical equipment. The Company distributes its products within domestic market and to overseas markets.

Sector

Healthcare Facilities & Services

Calendar

23/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for INKON Life Technology Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

7.33 CNY

Average target price

10.12 CNY

Spread / Average Target

+38.06%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

	1st Jan change	Capi.
INKON LIFE TECHNOLOGY CO., LTD.	-31.04%	642M
AIER EYE HOSPITAL GROUP CO., LTD.	-25.47%	15.13B
BANGKOK DUSIT MEDICAL SERVICES	-1.80%	11.77B
IHH HEALTHCARE	+3.48%	11.71B
ENCOMPASS HEALTH CORPORATION	+27.17%	8.54B
RAMSAY HEALTH CARE LIMITED	-6.29%	7.42B
THE ENSIGN GROUP, INC.	+6.08%	6.72B
MOUWASAT MEDICAL SERVICES COMPANY	+0.89%	6.02B
DALLAH HEALTHCARE COMPANY	-4.31%	4.28B
FORTIS HEALTHCARE LIMITED	+11.12%	4.21B

Hospitals, Clinics & Primary Care Services